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Reverse transcription (RTn) in HIV-infected cells occurs in a nucleoprotein complex termed the reverse transcription complex (RTC). RTCs
containing RT activity and integrase (IN) were shown to be heterogeneous in size and density on sucrose velocity and equilibrium gradients. WT
and Vif-deficient (Δvif) RTCs produced by infection with virus from permissive cells displayed similar sedimentation characteristics, while RTCs
from Δvif virus produced in non-permissive cells demonstrated a reduction in the major RTC form and more of the RTn products in rapidly
sedimenting structures. APOBEC3G derived from virions did not co-sediment with RTCs, but RTCs from Δvif infections showed elevated levels
of mutations in RTn products, consistent with APOBEC3G and other mutational mechanisms. The most mutated transcripts were present within
rapidly sedimenting RTCs. Thus, virus without functional vif, produced from non-permissive cells, forms abnormal RTCs that contain increased
mutation of RTC-associated RTn products in newly infected target cells.
© 2006 Elsevier Inc. All rights reserved.Keywords: Reverse transcription complexes; Non-permissive; APOBEC3G; Vif; HIV; MutationIntroduction
Although solubilised viral reverse transcriptase (RT) is
competent for reverse transcription (RTn) in vitro, in newly
infected cells, the RTn reaction is carried out by RT present
within a complex (reverse transcription complex, RTC) which
includes other viral and cellular factors. RTCs contain template
viral RNA and newly synthesised viral DNA, and our
laboratory and others have identified viral proteins, matrix
(MA), nucleocapsid (NC), protease (PR), Vpr, integrase (IN) in
addition to RT, within RTCs (Bukrinsky et al., 1993;
Karageorgos et al., 1993; Miller et al., 1997). Studies by
imaging in live cells, combining labelling of RTn products and
immunostaining of viral proteins, have also detected capsid
(CA) in some active RTCs (McDonald et al., 2002). When RTn
is completed to form pre-integration complexes, host factors⁎ Corresponding author. Fax: +61 8 8222 3543.
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doi:10.1016/j.virol.2006.03.027such as HMGI (Y) (Farnet and Bushman, 1997), barrier to
autointegration factor (BAF) (Lin and Engelman, 2003) and
lens epithelium-derived growth factor/p75 (LEGDF) (Llano et
al., 2004) are associated.
While a similar depth of detail regarding associated host
factors for early RTCs is not known, early RTn is a known target
for cellular restriction factors. APOBEC3G, and other cytidine
deaminase family members such as APOBEC3F and APO-
BEC3C, are present in non-permissive cells, and in the absence
of HIV Vif, are incorporated into virions leading to defects in
RTn in newly infected target cells (Bishop et al., 2004a;
Liddament et al., 2004; Sheehy et al., 2002; Zhang et al., 2003;
Zheng et al., 2004). This has previously been shown to be
mediated by cytidine deamination of newly synthesised minus
strand DNA during RTn leading to G → A transitions in the
viral genome (Harris et al., 2003; Lecossier et al., 2003;
Mangeat et al., 2003; Zhang et al., 2003). More recent evidence
however suggests that anti-viral effects of APBOEC3G may not
depend solely on cytidine deaminase activity (Newman et al.,
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reported to bind HIV RNA and inhibit endogenous RTn
(Goncalves et al., 1996; Li et al., 2004). The anti-viral actions
and the role of APOBEC enzymes that are incorporated into the
virion and transferred into newly infected target cell RTCs (the
site of anti-viral attack) have not been investigated. When Vif-
deficient (Δvif) virus is produced from permissive cells such as
CEM-SS, which lack APOBEC3G, the first round of infection
in either permissive or non-permissive cells is productive.
However, when Δvif virus is produced from non-permissive
cells such as Hut-78 that contain APOBEC3G, replication is
blocked at the level of RTn in newly infected target cells
(Courcoul et al., 1995; Gabuzda et al., 1992; Sova and Volsky,
1993; von Schwedler et al., 1993). These observed character-
istics for Δvif HIV replication can be explained by the actions
of Vif in reducing the incorporation of APOBEC3G into wild-
type (WT) virions (Harris et al., 2003; Kao et al., 2003a;
Mariani et al., 2003). However, the role of APOBEC3G and Vif
in RTC structure and function within target cells has not been
directly examined. Accordingly, we have compared the physical
characteristics of WT and Δvif RTCs and correlated the extent
of cytidine deamination of RTn products with changes in RTC
sedimentation properties and the presence of APOBEC3G
protein.
Results
Identification of wild type (WT) RTCs following cell-to-cell
infection
A cell-to-cell transmission model was used to induce a
synchronous, high multiplicity infection. Cell infections were
initiated by mixing chronically HIV-infected cells (H3B) with
uninfected non-permissive recipients (Hut-78), as previously
described (Li and Burrell, 1992). H3B cells do not produce
significant amounts of unintegrated DNA, but cell mixing
results in a dramatic increase in newly synthesised RTn
products followed by a productive replication cycle (Li and
Burrell, 1992). Six hours after co-culture, cytoplasmic cell
lysates were collected and subjected to sucrose velocity
gradient sedimentation (Karageorgos et al., 1993). Products
representing early (strong stop, ssDNA) or late (U5-gag) viral
RTn products were identified. The RTn products were
distributed broadly with early (ssDNA) sedimenting slightly
more slowly than late (U5-gag), and both peaks overlapping in
fraction (fr) 5 (Fig. 1A). Exogenous RT activity was present at
the top (fr 1) of the gradient, probably representing free RT
protein, and also in fr 3–7 (Fig. 1B). IN was detected primarily
in fr 5–7 by IP but was also detected in frs 4 and 8 in some
experiments (Fig. 1C). Thus, gradient fractions 4–7 were
identified to contain the majority of RTCs based on the co-
sedimentation of newly synthesised viral DNA, RT activity
and IN, and sedimentation characteristics consistent with those
previously reported for RTCs (Bukrinsky et al., 1993; Fassati
and Goff, 2001; Karageorgos et al., 1993). RTn products
detected at the top of the gradient most probably represent
dissociated, free DNA, while material at the bottom of thegradient (fr 11) represents rapidly sedimenting structures such
as aggregates.
When fr 5 was next subjected to sucrose equilibrium density
centrifugation, the viral DNA banded predominantly at 1.19–
1.25 g/ml sucrose (Fig. 1D), at a density consistent with
previous results from our laboratory (Karageorgos et al., 1993).
RTC forms containing predominantly early ssDNA banded in
the lighter fractions and forms with an ssDNA:U5-gag DNA
ratio of approximately 1:1 banded in the more dense fractions
(Fig. 1D). This region of the gradient contained exogenous RT
activity (Fig. 1E) and IN protein (Fig. 1F) consistent with the
view that it contained RTCs actively involved in virus
replication. The reproducibility of the gradient profile, as
assessed by the peak of RTn products observed in multiple
experiments, is shown in Table 1.
Sedimentation of WT and Vif-deficient (Δvif) RTCs following
cell-free virus infection
We next compared the physical properties of RTCs from WT
and Δvif virus infections. Cell-free virus infections of non-
permissive (Hut-78) cells were performed with either WT or
Δvif virus produced from permissive (CEM-SS) cells (i.e. cells
lacking APOBEC3G). At 6 h post-infection (pi), cytoplasmic
lysates were prepared and subjected to sucrose velocity gradient
sedimentation. Both ssDNA and 1st strand transfer (ST) DNA
were analysed, as a measure of active early RTn. The
distribution of RTn products was similar following cell-free
and cell-to-cell virus infections, with the major RTC forms
present in fr 5–7 and some RTn products present at the bottom
of the gradient (Figs. 1A, 2A). Moreover, RTn products from
both WTor Δvif virus possessed similar velocity sedimentation
characteristics (Fig. 2A). Replication of Δvif virus was
comparable to WT, with 55–80% of WT levels of viral DNA
present within cells and comparable levels of p24 being released
into the medium at 48 h pi (data not shown).
The total infected cell lysates were also subjected to
equilibrium density gradient centrifugation, and fractions were
tested for ST DNA (Fig. 2B). Two peaks of ST DNA were
observed banding at 1.15–1.17 and 1.21–1.25 g/ml sucrose. To
examine whether any of this material may have been derived
from input virus, lysates from cells kept at 4 °C to halt RTn
following viral attachment were fractionated similarly. This
yielded 70- to 100-fold lower levels of ST DNA banding
slightly higher with a density of 1.14 g/ml (data not shown).
Thus, the 1.15–1.17 and 1.21–1.25 g/ml sedimenting com-
plexes represent newly synthesised DNA rather than input
virus. The peak of ST DNA detected at 1.21–1.25 g/ml sucrose
is consistent with the equilibrium density of the predominant
RTC observed following WT cell-to-cell infection (Fig. 1C).
The additional major peak of RTn products detected at 1.15–
1.17 g/ml sucrose was reproducible (Table 1), not observed in
Fig. 1C where samples had previously been sedimented
through a gradient containing 0.5% Triton X-100 (Tx-100)
(Fig. 1A), and did not coincide with detection of endosomal
enzymes but did co-sediment with the transferrin receptor,
detected by Western blot (data not shown). These properties
Fig. 1. Identification of RTCs. (A) Velocity sedimentation of cytoplasmic lysates. Infections were initiated by cell mixing, and after 6 h cells were lysed in 0.1% Tx-100
and cytoplasmic extracts subjected to 10 ml, 15–30% linear sucrose velocity gradient sedimentation, as described in Materials and methods. One-milliliter fractions
were collected from the top of the gradient and analysed for the early and late RTn products ssDNA and U5-gag DNA by real time PCR. (B and E) Fractions were also
tested for exogenous RT activity by 3H-thymidine incorporation. −ve = background negative control. (C and F) Fractions were tested for the presence of IN protein by
IP. pre = negative control, pre-immune sera. (D) Equilibrium sedimentation of fr 5. Fraction 5 from panel Awas further subjected to 0–60% sucrose equilibrium density
centrifugation. One-milliliter fractions were collected from the top of the gradient and analysed as in panel A.
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represented RTCs in association with lipid, such as membrane
fragments. The biological relevance of RTCs sedimenting at
1.15–1.17 g/ml sucrose needs to be addressed further.
Cell-free infection with either WT or Δvif virus, produced
from permissive cells, resulted in qualitatively similar density
sedimentation characteristics of RTn products (Fig. 2B). Thus,
following infection with either WT or Δvif virus produced
from cells that do not express APOBEC3G, RTCs had
comparable velocity and density sedimentation characteristics
(Fig. 2).Next, Hut-78 (non-permissive) cells were infected with either
WT or Δvif cell-free virus, and at 24 h pi, the cells were har-
vested, trypsinised and re-cultured. After a further 24-h incuba-
tion, the supernatant containing released WTandΔvif virus was
collected, DNase-I-treated and filtered. This procedure was
used to prevent carry over of DNA or viral inoculum. These
freshly harvested virus stocks were used to infect Hut-78 cells.
The actual levels of input virus contained comparable levels of
p24 (1–3 ng/ml). At 6 h pi, the cells were lysed and cytoplasmic
lysates subjected to velocity gradient sedimentation as above.
RTn products from WT virus produced from non-permissive
Table 1
Reproducibility of RTC sedimentation as judged by mean ± SEM sedimentation
of peak DNA
Infection and gradient type Peak DNA 1 a Peak DNA 2 a
Cell–cell, velocity
Cytoplasmic lysate 1.092 ± 0.003 (6) b
Cell–cell, equilibrium
Fr 5 from velocity gradient 1.229 ± 0.010 (4)
Cell-free, velocity
WT 1.094 ± 0.003 (10)
Δvif, from permissive cells 1.090 ± 0.006 (3)
Δvif, from non-permissive cells 1.153 ± 0.018 (5)
Cell-free, equilibrium
WT 1.161 ± 0.004 (9) 1.223 ± 0.004 (9)
Δvif, from permissive cells 1.156 ± 0.019 (2) 1.232 ± 0.016 (2)
Δvif, from non-permissive cells 1.157 ± 0.008 (2) 1.217 ± 0.006 (2)
a Sucrose density (g/ml).
b Value for n = number of gradients.
Fig. 2. WT or Δvif RTCs produced following infection with virus from
permissive cells have similar sedimentation characteristics. Hut-78 cells were
infected with WT or Δvif virus produced from CEM-SS cells, at 20 ng p24/106
cells by centrifugal enhancement. At 6 h pi, cells were lysed in 0.1% Tx-100 and
cytoplasmic extracts sedimented. (A) Velocity gradient sedimentation of
cytoplasmic lysates. Three-hundred-microliter fractions were collected from
the top of the gradient. (B) Equilibrium density gradient sedimentation of
cytoplasmic lysates. Four 1-ml followed by ten 0.5-ml fractions were collected
from the top of the gradient. Fractions from panels A and B were analysed for
the presence of early RTn products (1st strand transfer, ST) by real time PCR.
Values represent mean ± SEM for the PCR reaction. The total amount ofΔvif ST
DNA represented 55–80% of WT levels. Data presented are from a single
representative infection.
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WT virus produced from permissive cells (Fig. 1A), with most
RTn products distributed in fr 5–7 (Fig. 3A). In contrast, in
Δvif-virus-infected cells, the level of RTn products in these
fractions (fr 5–7) was greatly reduced, and relatively more ST
DNA was detected in more rapidly sedimenting complexes (fr
8–11) (Fig. 3A). In some experiments, detectable RTn products
were scattered in fr 5–7 but no defined Δvif RTC peak was
observed. Following equilibrium density centrifugation of WT-
virus-infected cell lysates, two peaks of RTn products were
observed (Fig. 3B), similar to those in Fig. 2B. However,
compared to the profile seen with WT virus or Δvif virus
produced from permissive cells, the Δvif virus from non-
permissive cells gave reduced RTn products banding at
1.21–1.25 g/ml and some additional RTn products in fr 1–4
(1–1.14 g/ml) (Figs. 2B, 3B). RTn by Δvif virus was defective,
with only 25–30% of the levels of viral DNA observed with WT
virus using similar levels of input virus. The reproducibility of
the gradient profile, as assessed by the peak of RTn products
observed in multiple experiments, is shown in Table 1.
Thus, WT and Δvif virus produced RTCs of similar size,
density and capacity to carry out RTn, if they were derived from
infection with virus grown in permissive cells that lack
APOBEC3G. In contrast, if the infecting virus had been
grown in non-permissive cells which express APOBEC3G,
Δvif-derived RTCs sedimented more rapidly and synthesised
reduced levels of HIV DNA compared to WT-derived RTCs or
RTCs formed from virus grown in cells lacking APOBEC3G.
Δvif-derived RTCs also included some structures banding at a
lower density than WT RTCs.
APOBEC3G, detected by Western, does not co-sediment with
RTCs
WT and Δvif virus produced from non-permissive Hut-78
cells (which contain endogenous APOBEC3G) were used to
infect permissive APOBEC3G negative CEM-SS cells. AnyAPOBEC3G detected in CEM-SS lysates could thus only be
derived from incoming virions. APOBEC3G was shown by
Western blot to be present in virus derived from Hut-78 but not
CEM-SS cells (data not shown). Infected cells were lysed at 6 h
pi and cytoplasmic lysates examined by velocity gradient
centrifugation. RTn products from WT virus were predomi-
nantly detected in fr 5–7, suggesting the presence of RTCs in
these fractions (Fig. 4A), while Δvif RTn products were
distributed across the gradient with no peak in fr 5–7 (Fig. 4A).
The absolute levels of total ST DNA inΔvif infection were only
15% of those seen with WT virus using comparable levels of
inoculum.
Total protein was precipitated from individual gradient
fractions and analysed by Western blot using an APOBEC3G-
specific antibody. Low levels of the 42 kDa APOBEC3G
protein were detected in the upper gradient fractions for both
WT and Δvif infections, indicative of soluble APOBEC3G
dissociated from incoming virions in the target cells (Fig. 4B).
Smaller molecular weight APOBEC3G antibody-reactive
proteins were also detected in the same fractions, possibly
Fig. 4. APOBEC3G from virions does not co-sediment with RTCs in newly
infected cells. CEM-SS cells were infected by centrifugal enhancement at
10–60 ng p24/107 cells withWTorΔvif virus derived from acutely infected Hut-
78 cells. At 6 h pi, cells were lysed in 0.1% Tx-100 and cytoplasmic extracts
subjected to sucrose velocity gradient sedimentation. Three-hundred-microliter
fractionswere collected from the top of the gradient. (A) DNAwas extracted from
half of the fraction and analysed for the presence of early RTn products (ST) by
real time PCR. The total amount ofΔvif ST DNA represented 15% ofWT levels.
Values represent mean ± SEM for the PCR reaction. (B) Proteins from the
remaining portion of each fraction were precipitated with TCA and subjected to
SDS-PAGE and Western analysis for APOBEC3G.
Fig. 3. Δvif RTCs produced following infection with virus derived from non-
permissive cells have altered sedimentation properties. Hut-78 cells were
infected by centrifugal enhancement with 10–60 ng p24/107 cells of WTorΔvif
virus produced from acute infection of Hut-78 cells. At 6 h pi, cells were lysed in
0.1% Tx-100 and cytoplasmic extracts sedimented. (A) Velocity gradient
sedimentation of cytoplasmic lysates. Three-hundred-microliter fractions were
collected from the top of the gradient. (B) Equilibrium density gradient
sedimentation of cytoplasmic lysates. Four 1-ml followed by ten 0.5-ml
fractions were collected from the top of the gradient. Fractions from panels A
and B were analysed for the presence of early RTn products (ST) by real time
PCR. Values represent mean ± SEM for the PCR reaction. The total amount of
Δvif ST DNA represented 25–30% of WT levels. Data presented are from a
single representative infection.
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experiment to that in Fig. 4, the co-sedimentation of RT with
RTn products following velocity gradient sedimentation was
analysed by Western blot. Faint bands representing RT protein
were detected co-sedimenting with DNA in fr 5/6 (data not
shown) and the majority of RT sedimented as free protein at the
top of the gradient consistent with previous reports (Fassati and
Goff, 2001) and showing that detection of at least this RTC-
associated protein is possible in our system. The results shown
in Fig. 4 indicate that (1) APOBEC3G from non-permissive
viral producer cells is brought into newly infected target cells by
both WT and Δvif virus (2) under the mild detergent lysis and
separation conditions used, and at 6 h pi, virus-derived
APOBEC3G was not detected co-sedimenting with RTCs.
Vif-deficient RTCs contain mutated RTn products
Since APOBEC3G has been shown to deaminate single-
stranded HIV RTn products, RTn products were sequenced
across the U3 region of the LTR. The U3 region of the viral
genome was chosen since RTn of this region involves minusand plus strand single-stranded DNA intermediates that present
potential targets for APOBEC3G. WT and Δvif virus generated
from non-permissive Hut-78 cells was used to infect Hut-78
cells, and cytoplasmic lysates were subjected to velocity or
equilibrium gradient sedimentation. DNA was prepared from
fractions 5 and 9 or 10 (velocity gradient, from Figs. 5A and
3A) and fr 6 and 8.5 (equilibrium gradient, Fig. 3B), and 350 bp
from the U3 region of the LTR was PCR-amplified, cloned and
sequenced. Analysis of RTn products from the total pool ofΔvif
transcripts at 6 h pi showed a higher frequency of mutation
compared with WT virus (2.4% and 0.19% respectively),
suggesting increased susceptibility of Δvif RTn products to
mutation (Fig. 5B). G→A substitutions were the most common
mutation seen (32%), also with 32% of G → A substitutions
observed in the context of a GG dinucleotide, consistent with
the reported action of APOBEC3G (Beale et al., 2004; Bishop
et al., 2004a; Harris et al., 2003; Yu et al., 2004). The relative
contribution of G → A substitutions to the total number of
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previously (Bishop et al., 2004a; Harris et al., 2003; Lecossier et
al., 2003; Liddament et al., 2004; Mangeat et al., 2003; Zhang et
al., 2003; Zheng et al., 2004). Since our analysis is of an early
transcript at an earlier time point pi compared with the majority
of the literature, we also analysed cytoplasmic Δvif transcripts
from a cell lysate at 24 h pi and sequenced across a longer
(750 bp) nef-U3 transcript. Δvif RTn products showed high
frequency of mutation (2%), and again G → A substitutions
were the most common mutation seen with 65% in the GG
context. At this later time point, G → A substitutions
represented 64% of the total mutations, higher than that seen
at 6 h pi but still lower than that seen in most other studies
(Bishop et al., 2004a; Harris et al., 2003; Lecossier et al., 2003;
Liddament et al., 2004; Mangeat et al., 2003; Zhang et al., 2003;
Zheng et al., 2004). Thus, in our experimental system, Δvif
infection results in both G→ A and other base substitutions in
newly synthesised cytoplasmic transcripts.
Next, RTCs from Δvif infections sedimenting on velocity
gradients in fr 5 (normal RTCs) and fr 9/10 (altered RTC
structures) were compared (Fig. 5C). Higher levels of mutation
were observed in Δvif RTn products from the rapidly
sedimenting complexes (fr 9/10) compared with normally
sedimentingΔvif RTCs in fr 5 (1.45% and 0.44% respectively).
In fr 5, G → A base changes accounted for 64% of all
mutations, with mutations in the context of the GG dinucleotide
accounting for all substitutions. In contrast, in fr 9/10, G → A
base changes accounted for only 29% of mutations, with only
31% in the GG dinucleotide context. Thus, the primary
mutation in fr 5 was a G → A transition, consistent with the
described action of APOBEC3G cytidine deamination of minus
strand DNA. In fr 9/10, G → A mutation was still the most
common transition, although the context was not consistent
with the reported site preference for APOBEC3G (Beale et al.,
2004; Bishop et al., 2004a; Harris et al., 2003; Yu et al., 2004).
In fr 9/10, C → T changes were also observed that in the
majority of cases (76%) occurred in the CC dinucleotide context
consistent with APOBEC3G cytidine deamination of RNA
(Bishop et al., 2004b) or U3 plus strand DNA (Yu et al., 2004)
in addition to higher levels of other base substitutions.
Analysis of the distribution of mutations in individual clones
revealed that some clones contained a much higher number of
mutations than others (Fig. 5D). Analysis of the mutation
frequency per clone (350 bp) and hence of individual reverse
transcripts or RTCs demonstrated that fewer Δvif clones were
mutation-free (18% at 6 h 0% at 24 h) compared with WT
(45%), and the number of clones containing greater than two
mutations was more in Δvif reverse transcripts (45% of clones
with up to 30 mutation per clone at 6 h and 88% with up to 16
mutations per 350 bp) compared with WT (0%) (Fig. 5D).
Furthermore, Δvif RTn products derived from fr 9/10 gave rise
to 27% of clones with more than three mutational changes,
while no clones from RTn products in fr 5 had more than three
mutations (Fig. 5D). Therefore, progeny DNA from Δvif RTCs
contain more frequent mutations than DNA from WT RTCs.
The mutations seen in normally sedimenting Δvif RTCs (fr 5)
were consistent with the reported actions of APOBEC3Gcytidine deamination, while in the structurally altered rapidly
sedimenting Δvif RTCs (fr 9/10), many more and multiple
mutations were seen, including C → T transitions possibly
induced by APOBEC3G and other non-APOBEC3G related
mechanisms.
Discussion
This study has demonstrated that RTCs are heterogeneous in
size and density, consistent with a number of previous reports.
In addition, we have also identified that this heterogeneity in
part correlated with the extent to which the successive stages of
RTn have been completed. We have demonstrated that RTn
products produced following infection with Δvif virus
produced from non-permissive cells sediment differently
compared to RTCs from the same virus produced in permissive
cells or WT virus from either cell type, thereby relating different
properties of potential RTCs to the presence or absence of Vif-
related cellular restriction factors such as APOBEC3G in the
producer cell. We further showed that RTn products in RTCs
from infections with Δvif virus produced from non-permissive
cells contain more sequence mutations, including G–A and
other base substitutions, in newly synthesised viral DNA than
the WT virus produced in the same cells.
The sedimentation of the major WT RTC, containing IN
protein and RT activity, is similar to that seen previously from
our laboratory, spanning a range of approximately 160–320S
(Karageorgos et al., 1993). Those RTC species of more rapid
sedimentation contained DNA products that reflected a later
stage of RTn, suggesting that structural changes occur in RTCs
as RTn proceeds. Equilibrium centrifugation of the major RTC
fraction isolated from sucrose velocity gradients yielded
structures ranging in density from 1.19 to 1.25 g/ml. The
lightest density fraction contained RTCs with early RTn
products (high ss, low U5-gag), while the heaviest fraction
contained the most complete RTn products (equal ratio of ss:
U5-gag). The structures in all these fractions were thought to be
functional as they contained RTn products, IN and RT activity,
and sedimented at densities consistent with those of RTCs
previously reported from our laboratory (Karageorgos et al.,
1993). These heterogeneous structures may reflect intrinsically
distinct RTC species that differ in structure and/or protein
associations or the differences may be due to the progression of
the RTn process. Heterogeneity in size and structure of RTCs
has previously been observed by sedimentation characteristics
and EM analysis (Fassati and Goff, 2001; Nermut and Fassati,
2003), while McDonald et al. (2002) have identified active
RTCs that by immunoprotein staining in some instances
contained Vpr alone but in others contained both Vpr and
CA. The factors contributing to and functional consequences of
RTC heterogeneity need to be further characterised.
One factor that may influence RTC heterogeneity and
function is the association of host cell proteins. We investigated
the role of Vif and the Vif-dependent cellular restriction factor,
APOBEC3G, by examining RTCs from infections with Vif-
deficient HIV. RTn products derived from Δvif virus produced
from permissive cells lacking APOBEC3G had a very similar
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absence of APOBEC3G, Vif is not necessary for the formation
of normal RTCs in newly infected cells, consistent with the
known ability of Δvif virus produced from permissive cells to
support productive replication in target cells (Courcoul et al.,
1995; Gabuzda et al., 1992; Sova and Volsky, 1993; von
Schwedler et al., 1993). In contrast, RTn products derived from
Δvif virus produced in non-permissive, APOBEC3G contain-
ing cells showed different sedimentation properties, with a
marked reduction in the major RTC form, while RTn products
were mainly associated with rapidly sedimenting but less dense
structures. This correlates with evidence that the stage of
restriction of Δvif virus produced from non-permissive cells is
at the level of RTn in newly infected target cells (Nascimbeni et
al., 1998; Simon and Malim, 1996; Sova and Volsky, 1993; von
Schwedler et al., 1993). Therefore, the presence of APOBEC3G
in the virus producer cells correlated with alterations to the
normal RTC structures in newly infected cells.
Since the majority of reports suggest actions of APOBEC3G
derived from viral producer cells, APOBEC3G negative cells
were examined by Western blotting after infection with virus
derived from non-permissive cells. We detected low levels of
APOBEC3G in newly infected target cells derived from
incoming WT and Δvif virions. Vif is reported to induce
APOBEC3G degradation and virion exclusion (Kao et al.,
2003b; Mariani et al., 2003; Marin et al., 2003; Sheehy et al.,
2003; Yu et al., 2003). APOBEC3G is reduced and excluded
from WT virions in a dose-dependent manner (Kao et al.,
2003b; Sheehy et al., 2003) but can often still be detected (Khan
et al., 2005; Kobayashi et al., 2004), and thus detection of
APOBEC3G derived from WT virions seen in this study is not
unusual. APOBEC3G from infecting virions did not co-
sediment with HIV RTCs or RTn products at 6 h pi. Therefore,
we found no evidence to support the presence of APOBEC3G
protein from virions in RTCs at this time point. Thus, the
presence of APOBEC3G without Vif in the virus producer cell
is involved in altering the RTC and inducing mutation, but in
addition either (i) virion-associated APOBEC3G does not
remain part of the RTC after inducing these changes, (ii)
APOBEC3G is weakly associated with the RT, but is lost during
the mild detergent treatment used in this study (i.e. not firmly
bound to the RTC core) or (iii) APOBEC3G is present in RTCs
at levels below the sensitivity of Western blot detection. The
presence of APOBEC3G derived from virions in RTCs needs to
be addressed further through immunoprecipitation techniques,
similar to those described for IN (Fig. 1). APOBEC3G fromFig. 5. RTn products from Δvif infections contain higher levels of G–A and ot
enhancement with 10–60 ng p24/107 cells of WT or Δvif virus produced from ac
cytoplasmic extracts subjected to velocity gradient sedimentation. (A) Three-hundred
the presence of early RTn products (ST) by real time PCR. Values represent mean ±
PCR-amplified from WT or Δvif infections at 6 h pi, and the PCR products were cl
longer nef-U3 transcript was also cloned and sequenced from extrachromosomal DNA
the total number of bp sequenced are indicated. (C) A sequence of 350 bp within the
Figs. 3A and 5A) following Δvif infections at 6 h pi and the PCR products were clon
Values in the inner circle represent the number of clones assessed. Values in the outer
abundance of clones with the indicated number of mutations in the population. Data
gradient fraction 5 and 9/10 from 6 h pi.target cells may also play a role in restriction of RTn, but due to
the reported high molecular weight of APOBEC3G complexes
in target cells (Chiu et al., 2005), this should be thoroughly
investigated using co-sedimentation and immunoprecipitation
techniques.
Analysis of the sequence of early, newly transcribed RTn
products, however, demonstrated strong evidence supporting
APOBEC3G-mediated cytidine deamination in RTC structures.
Compared with WT, Δvif RTCs contained higher overall
frequencies of mutation including G→ A transitions and other
changes. When analysed in relation to sedimentation rate, Δvif
RTn products in rapidly sedimenting structures (fr 9/10)
displayed higher levels of mutation than Δvif RTn products
sedimenting at the same rate as the normal WT RTC (fr 5).
Mutations inΔvif RTCs from fr 5 primarily consisted of G→A
transitions consistent with APOBEC3G cytidine deamination of
minus strand DNA, while those in fr 9/10 also consisted of
possible APOBEC3G-induced C → T and other non-APO-
BEC3G-induced base changes. Results shown in this study
from 3 independent infection experiments indicate a much
lower contribution of G → A changes relative to the total
number of mutations than that seen in many other studies
(Bishop et al., 2004a; Harris et al., 2003; Lecossier et al., 2003;
Mangeat et al., 2003; Zhang et al., 2003; Zheng et al., 2004).
The level of non-G–A mutations seen in our study is higher at
6 h than 24 h pi and is more predominant in abnormally
sedimenting RTCs (fr 9/10) than normal structures (fr 5). This
may indicate that the transcripts containing these non-G–A
mutations in abnormal RTCs are defective and not maintained
throughout later infection. These other non G–Amutations may
arise due to (1) uracil excision and error-prone base excision
repair or PCR amplification of abasic templates rather than RTn
of ‘U’ and substitution of ‘A’; (2) altered RTC structure
resulting in decreased fidelity of RTn or attack of other host cell
defences on a more exposed RNA/DNA template; (3) actions of
other APOBEC enzymes or co-factors present in non-
permissive cells. The fact that we have observed these
transcripts that are not obvious in other studies may be due to
our experimental system, which we believe reflects that natural
infection process and differs to many other approaches used for
mutational analysis of Δvif transcripts in the literature: (1) we
used non-permissive viral producer cells rather than APO-
BEC3G-transfected producers (Bishop et al., 2004a; Harris et
al., 2003; Liddament et al., 2004; Mangeat et al., 2003; Zheng et
al., 2004), (2) we used non-permissive rather than permissive or
semi-permissive target cells (Bishop et al., 2004a; Harris et al.,her mutations than WT infections. Hut-78 cells were infected by centrifugal
ute infection of Hut-78 cells. At 6 h pi, cells were lysed in 0.1% Tx-100 and
-microliter fractions were collected from the top of the gradient and analysed for
SEM for the PCR reaction. (B) A sequence of 350 bp within the U3 region was
oned and sequenced. A sequence of 750 bp across the same U3 region but on a
followingΔvif infection at 24 h pi. The observed number of base transitions and
U3 region was PCR-amplified from velocity gradient fractions 5 or 9/10 (from
ed and sequenced. (D) Graphical representation of the distribution of mutations.
ring represent the number of mutations per clone. Percentage values represent the
are shown for the total WT and Δvif fractions examined at 6 h and 24 h pi and
87J.M. Carr et al. / Virology 351 (2006) 80–912003; Lecossier et al., 2003; Liddament et al., 2004; Mangeat et
al., 2003; Zhang et al., 2003; Zheng et al., 2004), (3) we
analysed an early RTn product rather than later transcripts
(Lecossier et al., 2003; Mangeat et al., 2003; Zheng et al., 2004)
and (4) we analysed cytoplasmic transcripts at an early timepoint pi rather than total cellular DNA at later time points that
may also reflect successfully integrated proviral forms (Bishop
et al., 2004a; Harris et al., 2003; Mangeat et al., 2003). Thus, in
our system, the actions of other factors that in addition to
APOBEC3G contribute to the non-permissive phenotype (Rose
88 J.M. Carr et al. / Virology 351 (2006) 80–91et al., 2005) and early events that are not represented at later
time points pi may become more apparent. In support of this,
elevated rates of other substitutions in addition to G → A
changes have previously been observed at 12 h pi with Δvif
virus produced from non-permissive cells infecting semi-
permissive C8166 cells (Zhang et al., 2003) and from infections
with virus from APOBEC3F-transfected producer cells (Lidda-
ment et al., 2004). In both cases, however, the levels of non-G–
A changes are lower that seen in our study. Additionally,
APOBEC3G-induced C → T changes have previously been
described in HIV RNA from Δvif virus produced in the
presence of rat APOBEC1 (Bishop et al., 2004b) and in the U3
region of HIV DNA, as also analysed in this study (Yu et al.,
2004). Thus, our results suggest that infection of non-
permissive HIV target cells with Δvif virus derived from
naturally non-permissive cells results in increased mutation of
early RTn products in RTCs, which involves both APOBEC3G
cytidine deamination and also other mutational mechanisms.
These alternative mutational mechanisms are rarely observed in
Δvif RTCs with velocity sedimentation characteristics similar
to WT virus, but occur more frequently in structurally altered,
rapidly sedimenting RTCs.
Recent evidence indicates that cytidine deaminase activity is
not the sole anti-viral mechanism of APOBEC3G action
(Newman et al., 2005; Shindo et al., 2003). In addition to
cytidine deamination, APOBEC3G could exert an anti-viral
activity via steric hindrance of RTCs due to protein–protein
interactions (Cen et al., 2004; Luo et al., 2004) or RNA binding
ability (Khan et al., 2005; Navarro et al., 2005; Svarovskaia et
al., 2004). Considering our observations of primarily G→ A in
structurally normal Δvif RTCs but more generalised mutations
in the rapidly sedimenting structures, we suggest that, in
addition to APOBEC3G-mediated cytidine deamination of RTn
products, APOBEC3G may alter the structure of RTCs and its
susceptibility to other mutagenic processes as suggested above.
Both of these latter effects could lead to RTC destruction and
defective infection.
In conclusion, our findings demonstrate that active RTCs are
physically heterogeneous, with differences related at least in
part to the stage of RTn. When APOBEC3G is present in virus
producer cells without sufficient Vif to counteract its actions,
the RTCs that are produced in newly infected target cells show a
loss of the normal structure and increased mutation of the viral
RTn products.
Materials and methods
Cells and plasmids
Hut-78 and CEM-SS cells were obtained from the NIH
AIDS Research and Reference Reagent Program (NIH AR and
RRP). H3B cells are a laboratory clone of H9 cells persistently
infected with HTLV-IIIB, as described previously (Li and
Burrell, 1992). pNL4.3 was obtained from the NIH AR and
RRP. pNL4.3 Δvif was generated by NdeI/PflMI digestion of
the SpeI/EcoRI fragment of pNL4.3, end filling and re-ligation.
The SpeI/EcoRI fragment containing Δvif was sub-cloned backinto pNL4.3 to re-generate a full-length infectious clone, similar
to previous Vif mutants (Karczewski and Strebel, 1996; Khan et
al., 2001). This mutation generates a frame shift at amino acid
28 of Vif and creates a stop codon at amino acid 40, resulting in
a severely truncated Vif protein.
Virus stocks
NL4.3 or Vif-defective (Δvif) NL4.3 virus was derived
from transfection of 293-T cells and amplification of virus
supernatant in CEM-SS. Virus stocks were DNase-I-treated
and filtered (0.22 μM) to remove contaminating DNA and
cells. TCID50 was determined by titrating virus on CEM-SS
cells. p24 content of virus stocks was determined by ELISA
(Roche). For generation of virus stocks from non-permissive
cells, Hut-78 cells were infected with either WT or Δvif cell-
free virus, and at 24 h pi, the cells were harvested, trypsinised
and re-cultured. After a further 24-h incubation, the superna-
tant containing released first round WT and Δvif virus was
collected, DNase-I-treated and filtered. This procedure was
used to prevent carry over of DNA or viral inoculum. These
freshly harvested virus stocks were used to infect Hut-78 cells,
and the actual levels of input virus were checked retrospec-
tively by p24 ELISA.
Infections and cell lysis
For cell-to-cell transmission of HIV, virus infected donor
cells (H3B) and uninfected recipient cells (Hut-78) were co-
cultured at a ratio of 1:4 (donor:recipient) at a density of 2 × 106
cell/ml, as previously described, achieving a highly synchro-
nous one-step infection (Li and Burrell, 1992). For cell-free
infections, Hut-78 cells were infected by centrifugal enhance-
ment with 10–60 ng of HIV p24 per 106 cells as described
previously (Vandegraaff et al., 2001b). Infections with WT and
Δvif virus produced in Hut-78 were performed with 5–10 ml of
freshly harvested virus supernatant for which the p24 content
was determined retrospectively. At 6 h pi, the cells were
harvested, trypsinised, washed and lysed for 15 min at room
temperature in lysis buffer A (10 mM Tris, pH 7.4, 150 mM
KCl, 5 mM MgCl2, 1 mM DTT, 20 μg/ml Aprotinin [LBA])
containing 0.1% Tx-100, as previously described (Karageorgos
et al., 1993). For cell-free infections, 100 ng/ml RNAse A was
included in the lysis buffer. Nuclei were pelleted (2500×g,
5 min), supernatants clarified by centrifugation (10,000×g,
10 min) and the resultant cytoplasmic extracts were adjusted to
8% (w/v) sucrose, 0.5% (v/v) Tx-100 and stored briefly at
−80 °C before analysis.
Velocity gradient fractionation of cell lysates
Cell lysates (1–5% gradient volume) were fractionated on a
10 ml (Fig. 1, 108 cells) or 3 ml (Figs. 2–5, 107 cells) linear 15–
30% sucrose gradient with 60% sucrose cushion in LBA
containing 0.5% Tx-100 at 4 °C. Sucrose gradients were
centrifuged in a SW40 rotor (Beckman) at 35,000 rpm for
50 min or SW60 rotor at 30,000 rpm for 65 min respectively.
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gradient, and sucrose density was determined by refractive
index.
Equilibrium density gradient fractionation of cell lysates
Cell lysates were fractionated on a 10 ml linear 0–60%
sucrose gradient in LBA. Sucrose gradients were centrifuged in
a SW40 rotor (Beckman) at 26,000 rpm for 16 h at 4 °C as
described previously (Karageorgos et al., 1993). Fractions were
collected from the top of the gradient, and sucrose density was
determined by refractive index.
Real time PCR for HIV RTn products
Sucrose gradient fractions were treated with proteinase K
and extracted with phenol chloroform, and the nucleic acid was
precipitated by ethanol followed by real time PCR analysis for
viral strong stop (ss), 1st strand transfer (ST) or U5-gag DNA.
Reactions utilised primer pairs CTAACTAGGGAACC-
CACTGC and CTGCTAGAGATTTTCCACAC (ssDNA),
GAGCCCTCAGATCCTGCATA and TCCCTAGTTAGCCA-
GAGAGC (1st ST DNA) and GGTAACTAGAGATCCCT-
CAG and AGAGCTCCTCTGGTTTCCCT (U5-gag DNA).
Reactions were performed using Syber green PCRmix (Qiagen)
and amplified by real time PCR cycling with a Rotor-gene 3000
(Corbett Research). Viral DNA copy numbers were determined
from genomic DNA standards derived from a mix of the H3B,
ACH2 and 8E5 chronically HIV-infected cell lines (Vandegraaff
et al., 2001a).
RT− assay
Exogenous RT assays were performed by methyl-3H-TTP
incorporation as described previously (Karageorgos et al.,
1993).
Cloning and sequencing of RTC-associated RTn products
DNA from sucrose fractions or extrachromosomal DNA
preparations cytoplasmic cell lysates were amplified by PCR
using Platinum Taq high fidelity DNA polymerase (Invitrogen)
and primer pairs for U3: CACACACAAGGCTACTTCCC and
GCCTACTCCCCAGTCCCGCCCAGG or nef-U3: GC-
AGCTGTAGATCTTAGCCACTT and CTTATATGCAGGAT-
CTGAGGGCTCG. The PCR products were cloned by TA
cloning (TOPO cloning kit, Invitrogen) and sequenced using
universal and reverse sequencing primers (Big Dye Terminator
v3.1, Applied Biosystems). WT and Δvif sequences at 6 h pi
were derived from both fr 5 and 9/10 (velocity gradient) and fr 6
and 8.5 (equilibrium gradient) following infection of Hut-78
cells with virus produced from Hut-78 cells.
Western blot analysis of APOBEC3G
Total protein from sucrose gradient fractions was preci-
pitated at 4 °C by addition of 1/10th volume 100% (w/v)trichloroacetic acid (TCA, Sigma Corp). The precipitated
protein was resuspended in 62. 5 mM Tris, 2% SDS, 5%
glycerol, pH 6.8 and 0.07% β-mercaptoethanol and subjected to
denaturing SDS-PAGE in 25 mM Tris, 192 mM Glycine, 0.1%
SDS with a 4% stacking and 12.5% separating gel. Separated
proteins were transferred to a nitrocellulose membrane, blocked
in Tris-buffered saline containing 0.1% (v/v) Tween-20 (TBS-
T) and 5% skim milk powder and then probed with 1:1000
diluted APOBEC3G antibody (NIH AR and RRP, cat # 9968;
Stopak et al., 2003). Membranes were then incubated with anti-
rabbit IgG–HRP secondary antibody conjugates, and the
proteins were visualised by chemiluminescence (Amersham
Biosciences).
Immunoprecipitation (IP) of HIV IN
Sucrose gradient fractions from 1 × 108 cell equivalents were
diluted separately in LBA containing 0.5% Tx-100 and
incubated with rabbit pre-immune sera (negative control) or
IN antisera (756, 757 and 758 mixed, AR and RP) rotating for
3 h at 4 °C. Equilibrated protein A sepharose (1/20th the
volume) was then added and the lysate incubated for a further
1 h at 4 °C. Protein antibody complexes were precipitated by
centrifugation and washed five times in cold LBA containing
0.5% Tx-100, with vortexing in between each wash. DNA
associated with the precipitated proteins was extracted by
proteinase K digestion, phenol chloroform extraction and
ethanol precipitation and analysed for HIV DNA by real time
PCR as described above.
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